Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2025-12-24 @ 4:52 PM
NCT ID:
NCT02963350
Brief Summary:
* To provide access to BMN 190 to patients with CLN2 disease who cannot participate in a clinical trial.
* To collect additional information on the safety and tolerability of BMN 190 administration in patients with CLN2 disease.
Study:
NCT02963350
Study Brief:
Protocol Section:
NCT02963350